TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Immunovia AB
Closing information (x1000 EUR)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
103
|
83
|
36 |
| Financial expenses |
1,636
|
371
|
1,732 |
| Earnings before taxes |
-15,105
|
-15,251
|
-14,549 |
| EBITDA |
-14,938
|
-14,429
|
-12,411 |
| Total assets |
27,011
|
48,285
|
65,871 |
| Current assets |
10,389
|
29,051
|
47,302 |
| Current liabilities |
2,164
|
3,202
|
3,366 |
| Equity capital |
21,908
|
42,428
|
59,716 |
| - share capital |
102
|
111
|
97 |
| Employees (average) |
64
|
66
|
63 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
81.1%
|
87.9%
|
90.7% |
| Turnover per employee |
2
|
1
|
1 |
| Profit as a percentage of turnover |
-14665.0%
|
-18374.7%
|
-40413.9% |
| Return on assets (ROA) |
-49.9%
|
-30.8%
|
-19.5% |
| Current ratio |
480.1%
|
907.3%
|
1405.3% |
| Return on equity (ROE) |
-68.9%
|
-35.9%
|
-24.4% |
| Change turnover |
27
|
47
|
1 |
| Change turnover % |
36%
|
133%
|
2% |
| Chg. No. of employees |
-2
|
3
|
15 |
| Chg. No. of employees % |
-3%
|
5%
|
31% |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.